Plain-English translation of NCT06519292 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is investigating whether immune checkpoint inhibitors—a powerful new class of cancer medications—may increase the risk of heart attacks, strokes, and blood clots. Researchers want to understand how these medications affect your heart and blood vessels over time, and whether the risk changes as you continue treatment.
While this medication has transformed cancer care, recent studies suggest it may increase the risk of serious heart and blood vessel problems. However, doctors don't yet understand why this happens or how to predict who is most at risk, so this study is collecting detailed heart imaging to fill that gap.
You likely qualify if…
You likely don't qualify if…
You would have a heart imaging scan (called a CT angiography) to take detailed pictures of your coronary arteries before or around the start of your cancer treatment, and researchers would follow your health over time. Depending on which group you're assigned to, you'll either be receiving the immune checkpoint inhibitor or receiving standard cancer treatment as usual. The study collects information about any heart-related events or health changes that occur during and after your cancer treatment.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Netherlands